Published in Vaccine Weekly, May 31st, 2006
Study 1: The integrase cofactor LEDGF/p75 plays a key role in the replication cycle of human immunodeficiency virus and is a potential antiviral target.
Researchers in Belgium report, "After identifying the interaction between the transcriptional co-activator lens epithelium -derived growth factor (LEDGF/p75) and the human immunodeficiency virus type 1 (HIV-1) integrase (IN), we have now investigated the role of LEDGF/p75 during HIV replication. Transient small interfering RNA-mediated knockdown of LEDGF/p75 in HeLaP4 cells resulted in a three- to five-fold inhibition of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-31)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.